80 related articles for article (PubMed ID: 12209786)
1. Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity.
Wang SS; Becerra-Arteaga A; Good TA
Biotechnol Bioeng; 2002 Oct; 80(1):50-9. PubMed ID: 12209786
[TBL] [Abstract][Full Text] [Related]
2. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
[TBL] [Abstract][Full Text] [Related]
3. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
[TBL] [Abstract][Full Text] [Related]
4. Small heat shock proteins differentially affect Abeta aggregation and toxicity.
Lee S; Carson K; Rice-Ficht A; Good T
Biochem Biophys Res Commun; 2006 Aug; 347(2):527-33. PubMed ID: 16828710
[TBL] [Abstract][Full Text] [Related]
5. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42.
Liu R; Barkhordarian H; Emadi S; Park CB; Sierks MR
Neurobiol Dis; 2005 Oct; 20(1):74-81. PubMed ID: 16137568
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
Kirkitadze MD; Kowalska A
Acta Biochim Pol; 2005; 52(2):417-23. PubMed ID: 15933761
[TBL] [Abstract][Full Text] [Related]
7. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
Kanapathipillai M; Lentzen G; Sierks M; Park CB
FEBS Lett; 2005 Aug; 579(21):4775-80. PubMed ID: 16098972
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35.
Clementi ME; Pezzotti M; Orsini F; Sampaolese B; Mezzogori D; Grassi C; Giardina B; Misiti F
Biochem Biophys Res Commun; 2006 Mar; 342(1):206-13. PubMed ID: 16472763
[TBL] [Abstract][Full Text] [Related]
9. Specific binding of amyloid-beta-protein to IMR-32 neuroblastoma cell membrane.
Inaba S; Okada T; Konakahara T; Kodaka M
J Pept Res; 2005 May; 65(5):485-90. PubMed ID: 15853942
[TBL] [Abstract][Full Text] [Related]
10. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
11. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.
Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L
J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616
[TBL] [Abstract][Full Text] [Related]
12. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
13. Self-assembly of Abeta(1-42) into globular neurotoxins.
Chromy BA; Nowak RJ; Lambert MP; Viola KL; Chang L; Velasco PT; Jones BW; Fernandez SJ; Lacor PN; Horowitz P; Finch CE; Krafft GA; Klein WL
Biochemistry; 2003 Nov; 42(44):12749-60. PubMed ID: 14596589
[TBL] [Abstract][Full Text] [Related]
14. In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour.
Datki Z; Papp R; Zádori D; Soós K; Fülöp L; Juhász A; Laskay G; Hetényi C; Mihalik E; Zarándi M; Penke B
Neurobiol Dis; 2004 Dec; 17(3):507-15. PubMed ID: 15571986
[TBL] [Abstract][Full Text] [Related]
15. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein.
Kerr ML; Gasperini R; Gibbs ME; Hou X; Shepherd CE; Strickland DK; Foa L; Lawen A; Small DH
J Neurochem; 2010 Mar; 112(5):1199-209. PubMed ID: 20002523
[TBL] [Abstract][Full Text] [Related]
17. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
[TBL] [Abstract][Full Text] [Related]
18. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen.
Tucker HM; Kihiko-Ehmann M; Estus S
J Neurosci Res; 2002 Oct; 70(2):249-55. PubMed ID: 12271474
[TBL] [Abstract][Full Text] [Related]
20. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
Sakono M; Zako T; Ueda H; Yohda M; Maeda M
FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
